From: Evaluation of models to predict prognosis in patients with advanced hepatocellular carcinoma treated with TACE combined with apatinib
model
C-index
95%CI
P
HAP score
0.742
0.744
0.853
-
Six-to-twelve
0.701
0.664
0.795
0.016
Up to seven
0.698
0.644
0.733
< 0.001
ALBI grade
0.601
0.531
0.712